NEWS
RESOURCES
PODCAST
Donate
Subscribe
Search

News

Biomarkers identifying disease progression

Dr Edwin Lim discusses his MS research journey and the importance of research funding. Dr Lim is exploring biomarkers to identify disease progression in MS.

news-tysabri

Revolutionising MS Treatment: New form of Tysabri® recommended for PBS listing

The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended the listing of natalizumab (Tysabri®) pre-filled syringe for subcutaneous (under the skin) injection on the Pharmaceutical Benefit Scheme (PBS).
Read more
Rohan Greenland The May 50K

From our CEO

CEO Rohan Greenland shares an update on The May 50K, thanking participants for their significant contributions. He then unveils MS Australia's plans to champion the invaluable role of MS Nurses on World MS Day.
Read more

What us to keep you in the loop? Subscribe today!

  • Enter your details

MS Australia
registered charity

Let's connect

Newsletter subscribe
Facebook-f Twitter Linkedin-in Youtube Spotify

Participate in MS Research

Quick links

© 2023 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT
Read More
Researchers acknowledge MS Research Australia’s success in accelerating MS research in AustraliaVideos
Celebrating ten years of accelerating MS researchNews

Newsletter subscription

  • Enter your details

Biomarkers identifying disease progression